Form 4: Organon & Co. CFO Matthew Walsh Reports Acquisition of 11,400 Shares

Matthew M. Walsh, CFO of Organon & Co., reports acquiring 11,400 shares of common stock at $8.82 per share on May 5, 2025, increasing his total holdings to 144,484 shares.

Summary

• On May 5, 2025, Matthew M. Walsh, the Chief Financial Officer of Organon & Co., acquired 11,400 shares of the company's common stock.
• The purchase price was $8.82 per share.
• Following this transaction, Walsh's total beneficial ownership of Organon & Co. common stock increased to 144,484 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a stock purchase by an executive. While insider buying can be seen as positive, it's a single transaction and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• The CFO's purchase of company stock could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This filing indicates the CFO's direct investment in the company's stock.

Stakeholder Impact

• The increased stake of the CFO in the company may align his interests more closely with those of shareholders.

Key Dates

Keywords

Organon & Co., Matthew M. Walsh, CFO, stock acquisition, Form 4, beneficial ownership, OGN